Stock events for Advanced Flower Capital, Inc. (AFCG)
Over the past six months, AFCG's stock price has been impacted by several events, including its conversion from a REIT to a BDC on January 1, 2026, which aimed to enhance long-term shareholder value. The company announced its Q4 and full year 2025 financial results on March 4, 2026, reporting a GAAP net income of $0.9 million for Q4 but a GAAP net loss of $(20.7) million for the full year, missing analyst expectations. AFCG declared a Q1 2026 dividend of $0.05 per common share and expanded its revolving credit facility by $30 million, increasing its total capacity to $80 million. In February 2026, the company committed $29 million to a senior term loan and provided a $60 million senior secured credit facility. Insiders, including Leonard M. Tannenbaum and Robyn Tannenbaum, made open-market purchases of common stock. The stock has experienced a significant decline, losing 46.7% over the past 12 months, with a share price of $2.81 as of April 2, 2026.
Demand Seasonality affecting Advanced Flower Capital, Inc.’s stock price
While there is no direct information detailing demand seasonality for Advanced Flower Capital's specific lending products and services, its business is intrinsically linked to the cannabis industry, which does exhibit seasonal trends. Cannabis businesses often experience seasonal demands, such as increased sales during holidays, leading to a need for inventory financing to stock up. Lenders to the cannabis industry, like AFCG, may see fluctuations in demand for their financing solutions as their clients navigate these seasonal business cycles, requiring capital for inventory, equipment, or working capital during peak or slower periods.
Overview of Advanced Flower Capital, Inc.’s business
Advanced Flower Capital, Inc. (AFCG) is a publicly traded business development company (BDC) that provides flexible credit solutions, mainly senior debt investments, to lower middle-market companies, particularly those in the U.S. cannabis industry in states where cannabis is legal. It also finances companies ancillary to the cannabis industry and, selectively, businesses outside the cannabis sector. The company, headquartered in West Palm Beach, Florida, was formerly AFC Gamma, Inc. and converted from a commercial mortgage REIT to a BDC on January 1, 2026. Its products include originating, structuring, underwriting, investing in, and managing senior secured loans and other debt securities, typically ranging from $10 million to over $100 million, secured by real estate, equipment, cash flows, and licenses or other assets.
AFCG’s Geographic footprint
Advanced Flower Capital, Inc. is based in West Palm Beach, Florida, and manages a diversified portfolio across various industries, geographies, and asset types throughout the United States. Its lending activities are particularly focused on U.S. middle-market companies operating in the cannabis industry within states where medical and/or adult-use cannabis is legal.
AFCG Corporate Image Assessment
Advanced Flower Capital's reputation has been shaped by its strategic conversion to a BDC, which is a positive event, but also by its underperforming stock and earnings miss, which negatively impacted investor confidence. Analyst sentiment is negative, with one analyst lowering earnings estimates and the stock holding a "Strong Sell" rating. Insider buying may signal internal confidence, but the company's exposure to the cannabis sector creates ongoing volatility risks.
Ownership
Advanced Flower Capital Inc. is primarily owned by insiders and institutional investors, with insiders holding approximately 74.02% of the shares, institutional shareholders owning about 24.28%, and retail investors holding roughly 1.71%. Robyn Tannenbaum is the largest individual shareholder, owning 40.10% of the company's shares, while Leonard M. Tannenbaum holds 28.79%. Key institutional holders include BlackRock, Inc., Vanguard Group Inc., CDC Financial, Inc., State Street Corp, Gsa Capital Partners Llp, Northern Trust Corp, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., Morgan Stanley, and Citadel Advisors Llc.
Ask Our Expert AI Analyst
Price Chart
$2.70